CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

Carcinoembryonic antigen (CEA) is the most widely used tumor marker in metastatic colorectal cancer (mCRC). However, its potential as a predictive marker of progression in mCRC during systemic chemotherapy, particularly in patients receiving monoclonal antibodies as a combination therapy, has remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Sora, Kim, Sun Young, Hong, Yong Sang, Kim, Tae Won, Choi, Ki Eun, Kim, Min Jung, Kim, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130020/
https://www.ncbi.nlm.nih.gov/pubmed/37185297
http://dx.doi.org/10.1038/s41598-023-33811-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130020/
https://www.ncbi.nlm.nih.gov/pubmed/37185297
http://dx.doi.org/10.1038/s41598-023-33811-x

Ejemplares similares